Araris is advancing three preclinical candidates for the treatment of hematological and solid tumors developed using its ...

Humanetics Corporation, a clinical-stage pharmaceutical company, has selected Lifecore Biomedical, a fully integrated CDMO, ...

To leverage Alteogen's ALT-B4 Hybrozyme platform technology for large volume subcutaneous administration of drugs.

Curia will expand its Glasgow, UK facility and offers updates on the ongoing expansion to its Albuquerque, NM facility.

Oncologi, Inc., a clinical-stage biopharmaceutical company, announced the acquisition of TargImmune Therapeutics, a biotechnology company specializing in novel tumor-targeted imm ...

Funds will help the companies create a platform for the manufacturing and characterization of AAV-based gene therapy vectors.

The combination of Mallinckrodt and Endo will create a strong pharmaceutical company with a diversified portfolio, enhanced ...

Achieves ISO9001, EFfCI GMP, and EXCiPACT certifications for its new manufacturing plant.

Batavia Biosciences has partnered with Vaccine Biotechnology City and MEVAC to enhance local vaccine manufacturing ...

HightByte’s PAS-X MES will integrate as part of the Körber Ecosystem Partner Program for improved data visibility and ...

As part of the investment, Emergent would lead U.S. manufacturing and commercialization efforts for four of Rocketvax’s ...

ENCell Co., Ltd., a South Korean biotech, has signed an MOU for collaboration in the field of CGT with Cell Resources ...